Affordable Access

deepdyve-link
Publisher Website

Enteric-coated mycophenolate sodium versus mycophenolate mofetil maintenance immunosuppression: outcomes analysis of the United Network for Organ Sharing/Organ Procurement and Transplantation Network database.

Authors
  • Irish, William1
  • Arcona, Stephen
  • Gifford, Ryan J
  • Baillie, G Mark
  • Cooper, Matthew
  • 1 CTI, Clinical Trial and Consulting Services, Raleigh, NC 27615, USA. [email protected]
Type
Published Article
Journal
Transplantation
Publication Date
Jul 15, 2010
Volume
90
Issue
1
Pages
23–30
Identifiers
DOI: 10.1097/TP.0b013e3181de9193
PMID: 20445488
Source
Medline
License
Unknown

Abstract

The adjusted BPAR rate difference at 3 years posttransplantation was less than 2% (13.6% vs. 11.7%); statistically significant because of the large number of patients included in the analysis, but a difference that may not be clinically meaningful. No differences in graft survival, new-onset diabetes mellitus, or renal function were observed between the treatment groups.

Report this publication

Statistics

Seen <100 times